SHORT MINI FUTURE WARRANT - MEDTRONIC Share Price

Certificat

DE000GG0FJ29

Market Closed - BOERSE MUENCHEN 11:57:16 26/06/2024 pm IST
1.3 EUR +0.78% Intraday chart for SHORT MINI FUTURE WARRANT - MEDTRONIC
Current month+9.24%
1 month+17.12%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Date Price Change
26/24/26 1.3 +0.78%
25/24/25 1.29 +10.26%
24/24/24 1.17 -1.68%
21/24/21 1.19 -7.03%
20/24/20 1.28 -3.03%

Real-time BOERSE MUENCHEN

Last update June 26, 2024 at 11:57 pm IST

More quotes

Static data

Product typeKnock-Out mit Stop Loss
Buy / SellPUT
Underlying MEDTRONIC PLC
Issuer Goldman Sachs
WKN GG0FJ2
ISINDE000GG0FJ29
Date issued 30/11/2023
Strike 93.88 $
Maturity Unlimited
Parity 10 : 1
Emission price 1.43
Emission volume N/A
Settlement Barausgleich
Currency EUR

Technical Indicators

Highest since issue 1.49
Lowest since issue 0.504

Company Profile

Medtronic plc is one of the world leaders in designing, manufacturing and marketing of medical equipment. Net sales break down by sector of activity as follows: - general and minimally invasive surgery (28.8%): surgical equipment, intra-operative monitoring systems, ventilation systems, etc.; - cardiac rhythm management (18.6%): implantable cardiac pacemakers, implantable defibrillators and automatic external defibrillators, cardiac ablation probes, etc.; - vascular diseases and cardiac surgery (17.4%): coronary stents, endoprostheses for aortal pathologies, distal protection systems, catheters, heart valve prostheses, auto-transfusion equipment, cardiac ablation devices, etc.; - spinal disorders (14.1%): spinal prostheses, disc prostheses, cerebral stimulation systems, bone graft technologies and mini-invasive spinal surgery, etc. The group also develops medical imagery-guided surgical navigation systems activity; - neurovascular, ear, nose and throat (ENT) and pelvic diseases (8.2%); - diabetes management (7.4%): internal and external glycemia monitoring systems and insulin pumps; - neurological disorders (5.5%): neurostimulation and pumped medication administration products, diagnostic tools, etc. Net sales are distributed geographically as follows: Ireland (0.3%), the United States (50.9%) and other (48.8%).
Sector
-
More about the company

Ratings for Medtronic plc

Trading Rating
Investor Rating
ESG Refinitiv
C
More Ratings

Consensus: Medtronic plc

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
33
Last Close Price
80.05 USD
Average target price
94.02 USD
Spread / Average Target
+17.46%
Consensus